CRPS occurs at rates of 5.5 to 26.2 cases per 100000 adults each year. Budapest criteria confirm 85 percent of clinical diagnoses. Full recovery occurs in 85 percent of patients who receive treatment within three months.
Key Takeaways
- Budapest criteria diagnose 85% of clinical CRPS cases
- Bone scintigraphy shows increased uptake in 90% acute phase
- MRI detects bone marrow edema in 80% early CRPS
- Autonomic testing (QSART) abnormal sudomotor in 65%, category: Diagnosis
- CRPS affects approximately 5.5 to 26.2 per 100,000 people annually in adults
- Incidence of CRPS is higher in females with a female-to-male ratio of 3.5:1 to 4:1
- CRPS Type I represents about 90% of all CRPS cases while Type II is 10%
- Trauma, especially fractures, precedes 60-85% of CRPS cases
- Immobilization after injury increases risk by 3-5 fold
- Female gender is a risk factor with odds ratio of 3.4
- 85% of CRPS patients recover fully if treated within 3 months
- Chronic CRPS (>1 year) persists in 30-50% despite treatment
- Pediatric recovery rate 90-95% with intensive PT
- Continuous burning pain is the hallmark symptom in 85-90% of CRPS patients
- Allodynia (pain from light touch) affects 70-80% of CRPS cases
Early CRPS diagnosis within three months leads to substantially better outcomes and higher recovery rates.
Related reading
01 · Category
Diagnosis15 stats
01
Budapest criteria diagnose 85% of clinical CRPS cases
02
Bone scintigraphy shows increased uptake in 90% acute phase
03
MRI detects bone marrow edema in 80% early CRPS
04
Laser Doppler imaging confirms vasomotor changes in 70%
05
Quantitative sensory testing (QST) abnormal in 95% patients
06
Thermography sensitivity 80-90% for temperature asymmetry
07
EMG shows denervation in CRPS II but normal in Type I 90%
08
V/D ratio on three-phase bone scan >0.7 in 85% acute cases
09
Skin biopsy reveals epidermal nerve fiber loss in 60% chronic
10
IASP criteria sensitivity 98% but specificity 36% critiqued
11
Ultrasound shows soft tissue swelling in 75% early CRPS
12
Functional MRI shows S1 hypoactivation in 70% patients
13
Nailfold capillaroscopy abnormal in 50-60% CRPS hands
14
McGill Pain Questionnaire differentiates CRPS pain quality 90%
15
Early diagnosis within 3 months improves outcomes in 80%
Interpretation
Diagnosis Interpretation
Despite a treasure chest of tests showing everything from bone scan blazes to brain scan blanks, diagnosing CRPS remains a clinical art of probabilities, where the most sensitive criteria catch nearly everyone but also net many imposters, making early clinical judgment the ultimate key to better outcomes.
02 · Category
Diagnosis, source url: https://pubmed.ncbi.nlm.nih.gov/12140465/1 stats
01
Autonomic testing (QSART) abnormal sudomotor in 65%, category: Diagnosis
Interpretation
Diagnosis, source url: https://pubmed.ncbi.nlm.nih.gov/12140465/ Interpretation
The diagnosis of CRPS often feels like a cruel joke, with the body's own wiring going haywire, as evidenced by the fact that nearly two-thirds of patients have abnormal sweat tests proving their nerves are in open rebellion.
03 · Category
Epidemiology20 stats
01
CRPS affects approximately 5.5 to 26.2 per 100,000 people annually in adults
02
Incidence of CRPS is higher in females with a female-to-male ratio of 3.5:1 to 4:1
03
CRPS Type I represents about 90% of all CRPS cases while Type II is 10%
04
The average age of onset for CRPS is between 40 and 60 years
05
Post-traumatic CRPS occurs in up to 20% of distal radius fractures
06
CRPS incidence peaks in the fifth decade of life with 26 cases per 100,000
07
Children account for less than 1% of CRPS cases but have better prognosis
08
Upper limb involvement occurs in 60% of CRPS cases compared to 40% lower limb
09
CRPS prevalence is estimated at 20 per 100,000 in the general population
10
Annual incidence in the Netherlands is 26.2 per 100,000 for females
11
CRPS following surgery occurs in 0.3% to 7% of carpal tunnel releases
12
Lifetime risk of CRPS after wrist fracture is 1-37% in women
13
CRPS is more common in Caucasians than other ethnic groups
14
Pediatric CRPS incidence is 1.5 per 100,000 per year
15
CRPS Type I is linked to 90-95% of cases without nerve injury
16
Incidence after total knee arthroplasty is 0.8-1.7%
17
CRPS affects 1 in 3,700 to 5,800 individuals yearly
18
Higher incidence in winter months possibly due to vitamin D deficiency
19
CRPS bilateral involvement occurs in 4-12% of cases
20
Global prevalence data is limited but estimated 5-20 per 100,000
Interpretation
Epidemiology Interpretation
While CRPS remains a relatively rare yet profoundly life-altering condition, its favorite target appears to be a Caucasian woman in her 40s or 50s who has suffered a limb injury, especially in the darker months, creating a perfect storm of pain that is as geographically specific to a wrist or hand as it is demographically predictable.
04 · Category
Etiology17 stats
01
Trauma, especially fractures, precedes 60-85% of CRPS cases
02
Immobilization after injury increases risk by 3-5 fold
03
Female gender is a risk factor with odds ratio of 3.4
04
Smoking doubles the risk of developing CRPS post-fracture
05
Genetic predisposition linked to HLA-DR15 in 20-30% cases
06
Psychological stress pre-trauma increases susceptibility OR 2.5
07
Low vitamin C intake raises post-fracture CRPS risk by 3x
08
Nerve injury directly causes CRPS II in all cases by definition
09
Autoimmune mechanisms implicated with autoantibodies in 40% serum
10
Inflammation via TNF-alpha elevated in 70% of CRPS biopsies
11
Central sensitization contributes in 80% chronic cases
12
Migraine history increases CRPS risk OR 2.1
13
Cast immobilization >2 weeks triples risk post-fracture
14
Astrocyte activation in spinal cord seen in 60% animal models
15
Cortical reorganization on fMRI in 75% of patients
16
Viral infections precede 5-10% of CRPS cases
17
Older age at injury (>50) reduces incidence but worsens severity
Interpretation
Etiology Interpretation
Crps appears to be a perfect storm where a traumatic spark, often a fracture, lands on a personal tinderbox of genetics, inflammation, and life factors like smoking or stress, which is then vigorously fanned by the well-meaning but counterproductive act of prolonged immobilization.
More related reading
05 · Category
Prognosis14 stats
01
85% of CRPS patients recover fully if treated within 3 months
02
Chronic CRPS (>1 year) persists in 30-50% despite treatment
03
Pediatric recovery rate 90-95% with intensive PT
04
Disability lasting >5 years in 15-20% severe cases
05
Suicide risk 5-10 times higher in chronic CRPS patients
06
Functional improvement in 70% with early bisphosphonate therapy
07
CRPS spreads to other limbs in 8-15% over 2 years
08
Quality of life SF-36 scores 50% lower than general population
09
20-30% develop contractures if untreated >6 months
10
Relapse rate 10-20% after apparent remission
11
Better prognosis in lower limbs vs upper (80% vs 65% recovery)
12
Opioid use leads to poorer long-term outcomes in 60%
13
50% achieve >50% pain reduction at 5 years with SCS
14
Depression comorbidity predicts worse prognosis OR 2.8
Interpretation
Prognosis Interpretation
CRPS hands you a brutal ultimatum: sprint into aggressive, early treatment and you’re likely to win your life back, but hesitate and you risk a long, grim war where pain spreads, the body stiffens, and the mind bears a heavy burden.
06 · Category
Symptoms19 stats
01
Continuous burning pain is the hallmark symptom in 85-90% of CRPS patients
02
Allodynia (pain from light touch) affects 70-80% of CRPS cases
03
Edema or swelling occurs in 80% of upper limb CRPS patients
04
Skin temperature asymmetry greater than 1°C in 75% of acute CRPS
05
Hyperalgesia (increased pain to noxious stimuli) in 80-90% of patients
06
Motor dysfunction like weakness or dystonia in 40-50% of cases
07
Trophic changes (hair, nail, skin) observed in 60-70% over time
08
Sudomotor abnormalities (sweating changes) in 50-70% of CRPS I patients
09
Joint stiffness and limited range of motion in 70% of affected limbs
10
Color changes (red, blue, mottled) in 80% during flares
11
Pain intensity averages 7-9 on VAS scale in chronic CRPS
12
Sensory loss or hypoesthesia in 30-50% of long-term cases
13
Tremor present in 20-30% of CRPS patients
14
Myoclonic jerks or dystonia in 15-25% of pediatric CRPS
15
Fatigue reported by 60-70% of CRPS sufferers
16
Sleep disturbance in 75-85% due to nocturnal pain exacerbations
17
Cognitive impairment like concentration issues in 50% chronic cases
18
Spread of symptoms to contralateral limb in 8-12%
19
Atrophy of muscles in 40-60% of untreated chronic CRPS
Interpretation
Symptoms Interpretation
Imagine a condition that, with the ruthless efficiency of a passive-aggressive office manager, ensures 85-90% of its subjects are perpetually on fire, while also micromanaging a revolting portfolio of swelling, color-changing skin, malfunctioning sweat glands, and a special bonus menu of tremors, brain fog, and the occasional uninvited symptom in your other limb.
07 · Category
Treatment15 stats
01
Physical therapy leads to full recovery in 80% pediatric cases
02
Vitamin C 500mg daily reduces post-fracture CRPS by 57%
03
Gabapentin reduces pain by 30-50% in 60% of patients
04
Bisphosphonates like pamidronate improve pain in 70% acute CRPS
05
Spinal cord stimulation (SCS) provides 50% pain relief in 60% long-term
06
Graded motor imagery therapy success rate 70-80% early stage
07
Ketamine infusions reduce pain scores by 4-5 points VAS in 50%
08
Mirror therapy improves function in 65% upper limb CRPS
09
NSAIDs effective for mild cases in 40-50% initially
10
Intrathecal baclofen reduces dystonia in 55% refractory cases
11
Desensitization therapy decreases allodynia in 70% patients
12
IVIG shows 70% improvement in small open-label trials
13
Multidisciplinary approach recovers 85% within 1 year early diagnosis
14
TENS provides short-term relief in 50-60% daily use
15
Antidepressants like amitriptyline help 40% neuropathic pain component
Interpretation
Treatment Interpretation
The encouraging statistics reveal a clear battle plan: a swift, multi-pronged attack with physical therapy and early psychological intervention offers the best chance for a full retreat, while a stubbornly entrenched enemy may require a specialized arsenal of targeted drugs and advanced neuromodulation to force a painful stalemate.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Kevin O'Brien. (2026, February 27). Crps Statistics. Gitnux. https://gitnux.org/crps-statistics
MLA
Kevin O'Brien. "Crps Statistics." Gitnux, 27 Feb 2026, https://gitnux.org/crps-statistics.
Chicago
Kevin O'Brien. 2026. "Crps Statistics." Gitnux. https://gitnux.org/crps-statistics.
Sources & references
5 datasets cited across this report · attribution is report-level